sapientrade
Long

STEM. Is it too early? or just the right time.

NASDAQ:STEM   STEMCELLS INC
60 0 0
Trade idea. Choppy. Pay close attention to RSI and MAC D histo. Price targets in blue upon validation.

First Half 2014: Initiate Phase II efficacy trial in spinal cord treatment

2014: Initiate Phase II efficacy trial in AMD            

2015: Interim results of proof of concept trials on both AMD             and spinal cord injuries

2016: The company plans to file an IND for the safety and efficacy of HuCNS-SC cells to restore memory loss in Alzheimer's patients.
Ideas Scripts Chart
United States
United Kingdom
India
España
Italia
Brasil
Россия
Türkiye
日本
한국
Home Stock Screener Economic Calendar How It Works Chart Features House Rules Moderators For the WEB Widgets Stock Charting Library Priority Support Feature Request Blog & News FAQ Help & Wiki Twitter
Private Messages Chat Ideas Published Followers Following Priority Support Public Profile Profile Settings Billing Sign Out